NCT01192971 2023-03-03
HCC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
Clinical Trials
4 trialsNCT03389256 2018-01-03
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT03199677 2017-07-02
A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer
ChineseAMS
Phase 2 Unknown
NCT01270386 2012-02-10
A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed